Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.

Odutola A, Ota MOC, Antonio M, Ogundare EO, Saidu Y, Owiafe PK, Worwui A, Idoko OT, Owolabi O, Kampmann B, Greenwood BM, Alderson M, Traskine M, Swinnen K, Verlant V, Dobbelaere K, Borys D.

Vaccine. 2019 May 1;37(19):2586-2599. doi: 10.1016/j.vaccine.2019.03.033. Epub 2019 Apr 8.

2.

Rapid growth is a dominant predictor of hepcidin suppression and declining ferritin in Gambian infants.

Armitage AE, Agbla SC, Betts M, Sise EA, Jallow MW, Sambou E, Darboe B, Worwui A, Weinstock GM, Antonio M, Pasricha SR, Prentice AM, Drakesmith H, Darboe MK, Kwambana-Adams BA.

Haematologica. 2019 Aug;104(8):1542-1553. doi: 10.3324/haematol.2018.210146. Epub 2019 Feb 7.

3.

Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study.

Mwesigwa J, Achan J, Affara M, Wathuo M, Worwui A, Mohammed NI, Kanuteh F, Prom A, Dierickx S, di Tanna GL, Nwakanma D, Bousema T, Drakeley C, Van Geertruyden JP, D'Alessandro U.

Clin Infect Dis. 2019 Jul 2;69(2):278-286. doi: 10.1093/cid/ciy870.

4.

Meningococcus serogroup C clonal complex ST-10217 outbreak in Zamfara State, Northern Nigeria.

Kwambana-Adams BA, Amaza RC, Okoi C, Rabiu M, Worwui A, Foster-Nyarko E, Ebruke B, Sesay AK, Senghore M, Umar AS, Usman R, Atiku A, Abdullahi G, Buhari Y, Sani R, Bako HU, Abdullahi B, Yarima AI, Sikiru B, Moses AO, Popoola MO, Ekeng E, Olayinka A, Mba N, Kankia A, Mamadu IN, Okudo I, Stephen M, Ronveaux O, Busuttil J, Mwenda JM, Abdulaziz M, Gummi SA, Adedeji A, Bita A, Omar L, Djingarey MH, Alemu W, D'Alessandro U, Ihekweazu C, Antonio M.

Sci Rep. 2018 Sep 21;8(1):14194. doi: 10.1038/s41598-018-32475-2.

5.

Do hotspots fuel malaria transmission: a village-scale spatio-temporal analysis of a 2-year cohort study in The Gambia.

Stresman GH, Mwesigwa J, Achan J, Giorgi E, Worwui A, Jawara M, Di Tanna GL, Bousema T, Van Geertruyden JP, Drakeley C, D'Alessandro U.

BMC Med. 2018 Sep 14;16(1):160. doi: 10.1186/s12916-018-1141-4.

6.

Consistent signatures of selection from genomic analysis of pairs of temporal and spatial Plasmodium falciparum populations from The Gambia.

Amambua-Ngwa A, Jeffries D, Amato R, Worwui A, Karim M, Ceesay S, Nyang H, Nwakanma D, Okebe J, Kwiatkowski D, Conway DJ, D'Alessandro U.

Sci Rep. 2018 Jun 26;8(1):9687. doi: 10.1038/s41598-018-28017-5.

7.

Residual malaria transmission dynamics varies across The Gambia despite high coverage of control interventions.

Mwesigwa J, Achan J, Di Tanna GL, Affara M, Jawara M, Worwui A, Hamid-Adiamoh M, Kanuteh F, Ceesay S, Bousema T, Drakeley C, Grietens KP, Lindsay SW, Van Geertruyden JP, D'Alessandro U.

PLoS One. 2017 Nov 2;12(11):e0187059. doi: 10.1371/journal.pone.0187059. eCollection 2017.

8.

Rapid replacement by non-vaccine pneumococcal serotypes may mitigate the impact of the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecology.

Kwambana-Adams B, Hanson B, Worwui A, Agbla S, Foster-Nyarko E, Ceesay F, Ebruke C, Egere U, Zhou Y, Ndukum M, Sodergren E, Barer M, Adegbola R, Weinstock G, Antonio M.

Sci Rep. 2017 Aug 15;7(1):8127. doi: 10.1038/s41598-017-08717-0.

9.

Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study.

Odutola A, Ota MOC, Antonio M, Ogundare EO, Saidu Y, Foster-Nyarko E, Owiafe PK, Ceesay F, Worwui A, Idoko OT, Owolabi O, Bojang A, Jarju S, Drammeh I, Kampmann B, Greenwood BM, Alderson M, Traskine M, Devos N, Schoonbroodt S, Swinnen K, Verlant V, Dobbelaere K, Borys D.

Vaccine. 2017 May 2;35(19):2531-2542. doi: 10.1016/j.vaccine.2017.03.071. Epub 2017 Apr 4.

10.

Exceptionally long-range haplotypes in Plasmodium falciparum chromosome 6 maintained in an endemic African population.

Amambua-Ngwa A, Danso B, Worwui A, Ceesay S, Davies N, Jeffries D, D'Alessandro U, Conway D.

Malar J. 2016 Oct 21;15(1):515.

11.

An outbreak of pneumococcal meningitis among older children (≥5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana.

Kwambana-Adams BA, Asiedu-Bekoe F, Sarkodie B, Afreh OK, Kuma GK, Owusu-Okyere G, Foster-Nyarko E, Ohene SA, Okot C, Worwui AK, Okoi C, Senghore M, Otu JK, Ebruke C, Bannerman R, Amponsa-Achiano K, Opare D, Kay G, Letsa T, Kaluwa O, Appiah-Denkyira E, Bampoe V, Zaman SM, Pallen MJ, D'Alessandro U, Mwenda JM, Antonio M.

BMC Infect Dis. 2016 Oct 18;16(1):575.

12.

High genetic diversity of Staphylococcus aureus strains colonising the nasopharynx of Gambian villagers before widespread use of pneumococcal conjugate vaccines.

Ebruke C, Dione MM, Walter B, Worwui A, Adegbola RA, Roca A, Antonio M.

BMC Microbiol. 2016 Mar 12;16:38. doi: 10.1186/s12866-016-0661-3.

13.

Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2-4 years: A phase II randomized study.

Odutola A, Ota MO, Ogundare EO, Antonio M, Owiafe P, Worwui A, Greenwood B, Alderson M, Traskine M, Verlant V, Dobbelaere K, Borys D.

Hum Vaccin Immunother. 2016;12(2):393-402. doi: 10.1080/21645515.2015.1111496.

14.

Risk factors for delay in age-appropriate vaccinations among Gambian children.

Odutola A, Afolabi MO, Ogundare EO, Lowe-Jallow YN, Worwui A, Okebe J, Ota MO.

BMC Health Serv Res. 2015 Aug 28;15:346. doi: 10.1186/s12913-015-1015-9.

15.

Population genetic analyses of Helicobacter pylori isolates from Gambian adults and children.

Secka O, Moodley Y, Antonio M, Berg DE, Tapgun M, Walton R, Worwui A, Thomas V, Corrah T, Thomas JE, Adegbola RA.

PLoS One. 2014 Oct 13;9(10):e109466. doi: 10.1371/journal.pone.0109466. eCollection 2014.

16.

Lessons in participant retention in the course of a randomized controlled clinical trial.

Idoko OT, Owolabi OA, Odutola AA, Ogundare O, Worwui A, Saidu Y, Smith-Sanneh A, Tunkara A, Sey G, Sanyang A, Mendy P, Ota MO.

BMC Res Notes. 2014 Oct 9;7:706. doi: 10.1186/1756-0500-7-706.

17.

Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution.

Janha RE, Worwui A, Linton KJ, Shaheen SO, Sisay-Joof F, Walton RT.

BMC Evol Biol. 2014 Apr 1;14:71. doi: 10.1186/1471-2148-14-71.

18.

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

Yindom LM, Leligdowicz A, Martin MP, Gao X, Qi Y, Zaman SM, van der Loeff MS, van Tienen C, Jaye A, Aveika A, Worwui A, Diatta M, Vincent T, Whittle HC, Rowland-Jones SL, Walton R, Carrington M.

J Virol. 2010 Aug;84(16):8202-8. doi: 10.1128/JVI.00116-10. Epub 2010 Jun 2.

19.

Effects of genetic variation at the CYP2C19/CYP2C9 locus on pharmacokinetics of chlorcycloguanil in adult Gambians.

Janha RE, Sisay-Joof F, Hamid-Adiamoh M, Worwui A, Chapman HL, Opara H, Dunyo S, Milligan P, Rockett K, Winstanley P, Pirmohamed M, Miller AK, Conway DJ, Walton RT.

Pharmacogenomics. 2009 Sep;10(9):1423-31. doi: 10.2217/pgs.09.72.

20.

DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans.

Olesen R, Wejse C, Velez DR, Bisseye C, Sodemann M, Aaby P, Rabna P, Worwui A, Chapman H, Diatta M, Adegbola RA, Hill PC, Østergaard L, Williams SM, Sirugo G.

Genes Immun. 2007 Sep;8(6):456-67. Epub 2007 Jul 5.

PMID:
17611589

Supplemental Content

Loading ...
Support Center